Who made lots of money from this biotech bankruptcy? Hint: It wasn't Martin Shkreli
July 20, 2016 at 15:27 PM EDT
The Bay Area drug company that industry bad boy Martin Shkreli led for nearly four weeks late last year emerged last month from Chapter 11 bankruptcy reorganization. Here's how much its advisors got paid for their work to right the ship.
